The global Food for Special Medical Purpose Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Nutritionally Complete Foods, Nutritionally Complete Foods with A Disease, Nutritionally Incomplete Foods), By Form (Oral, Injectable, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings, Others)
In 2024, the Food for Special Medical Purpose market is witnessing robust growth, driven by the increasing demand for nutritionally tailored products designed to meet specific medical and dietary needs. Foods for special medical purposes, including enteral nutrition, low-protein foods, and specialized infant formulas, are critical for individuals with specific health conditions. The market benefits from advancements in nutritional science and formulation technologies, the growing trend of personalized nutrition, and the expansion of the healthcare and wellness sectors. Additionally, the rising awareness of the importance of specialized nutrition for managing health conditions is contributing to market growth.
The market report analyses the leading companies in the industry including Danone S.A., Darman Ara Corp, GFI - Gruppo Farmaimpresa, Guangzhou New Health Biotechnology Co. Ltd, LENUS Pharma GesmbH, Mead Johnson & Company LLC , Nestlé S.A., and Others.
One prominent trend in the food for special medical purpose market is the increasing demand for personalized nutrition and therapeutic foods. With advancements in healthcare and nutrition science, there is a growing recognition of the importance of tailored dietary interventions for managing various medical conditions and supporting overall health and well-being. This trend is driven by the rise in chronic diseases, aging populations, and the emphasis on preventive healthcare, prompting healthcare professionals and consumers to seek specialized food products designed for specific medical needs. Food for special medical purpose addresses this trend by offering nutritionally balanced and targeted solutions for individuals with specific dietary requirements and health challenges.
A key driver propelling the food for special medical purpose market is health concerns and clinical recommendations. Patients with medical conditions such as diabetes, cardiovascular disease, gastrointestinal disorders, renal insufficiency, and metabolic disorders require specialized dietary management to improve health outcomes, manage symptoms, and prevent complications. Healthcare professionals play a crucial role in prescribing and recommending food for special medical purpose products based on individual nutritional needs, medical history, treatment goals, and dietary restrictions. The driver behind this trend is the need for effective nutritional support, therapeutic benefits, and adherence to medical guidelines, driving demand for specialized food formulations tailored to specific health conditions.
A significant opportunity in the food for special medical purpose market lies in innovation in functional ingredients and personalized nutrition solutions. Companies can capitalize on this opportunity by developing food products enriched with functional nutrients, bioactive compounds, vitamins, minerals, and dietary fibers that address specific health concerns and provide therapeutic benefits. Additionally, there's potential for offering personalized nutrition services, such as dietary counseling, meal planning, and customized food formulations tailored to individual nutritional requirements, medical conditions, and treatment protocols. By focusing on innovation, customization, and addressing the diverse needs of patients and healthcare professionals, companies can create value-added products, improve patient outcomes, and contribute to the growth of the food for special medical purpose segment.
In the Food for Special Medical Purpose Market, the Nutritionally Complete Foods segment emerges as the largest. These products are specifically formulated to provide all essential nutrients in precise amounts required by individuals with specific medical conditions or dietary needs. They are designed to be nutritionally balanced and are often used as sole sources of nutrition or as supplements in managing medical conditions such as malnutrition, gastrointestinal disorders, metabolic disorders, or other health challenges. Nutritionally complete foods are meticulously crafted to meet stringent nutritional guidelines, ensuring that patients receive adequate nourishment while managing their health conditions effectively. The segment's dominance can be attributed to the increasing prevalence of chronic diseases, aging populations, and the rising awareness among healthcare providers and patients regarding the importance of precise nutritional support in managing health conditions. As medical science advances, the demand for specialized nutrition solutions continues to grow, underscoring the significance of nutritionally complete foods in the Food for Special Medical Purpose market.
In the Food for Special Medical Purpose Market, the Oral Form segment stands out as the fastest growing to 2032. Oral formulations of medical foods and nutritional supplements are gaining significant traction due to their convenience, ease of administration, and patient compliance. These products are designed to be consumed orally, either in liquid, powder, or solid form, providing essential nutrients tailored to meet specific medical needs. The growth in this segment is driven by several factors, including advancements in formulation technology that enhance bioavailability and palatability, expanding patient preference for non-invasive treatment options, and increasing healthcare expenditure on preventive and therapeutic nutrition solutions. Further, the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal conditions necessitates effective oral nutrition strategies to support disease management and overall health. As healthcare systems worldwide prioritize personalized and patient-centric care, the oral form segment in the Food for Special Medical Purpose market is poised for robust growth, catering to diverse medical and nutritional needs.
In the Food for Special Medical Purpose Market, the Hospitals segment emerges as the largest. Hospitals play a pivotal role in the provision of specialized medical foods tailored to meet the nutritional requirements of patients with specific medical conditions or those undergoing treatment. These settings often have dedicated dietetics departments that prescribe and manage nutritional therapies, integrating them into overall patient care plans. The demand within hospitals is driven by the need for comprehensive nutritional support for patients recovering from surgeries, managing chronic illnesses, or undergoing intensive treatments like chemotherapy. The hospital environment ensures rigorous adherence to dietary guidelines and regulations, ensuring patient safety and therapeutic efficacy. Further, hospitals benefit from institutional purchasing power, enabling them to procure medical foods in bulk and streamline distribution across various departments and wards. As healthcare continues to evolve towards personalized medicine and holistic patient care, the hospital segment remains pivotal in driving the growth of the Food for Special Medical Purpose market, catering to diverse patient needs with specialized nutritional solutions.
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Danone S.A.
Darman Ara Corp
GFI - Gruppo Farmaimpresa
Guangzhou New Health Biotechnology Co. Ltd
LENUS Pharma GesmbH
Mead Johnson & Company LLC
Nestlé S.A.
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Food for Special Medical Purpose Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Food for Special Medical Purpose Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Food for Special Medical Purpose Market Share by Company, 2023
4.1.2. Product Offerings of Leading Food for Special Medical Purpose Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Food for Special Medical Purpose Market Drivers
6.2. Food for Special Medical Purpose Market Challenges
6.6. Food for Special Medical Purpose Market Opportunities
6.4. Food for Special Medical Purpose Market Trends
Chapter 7. Global Food for Special Medical Purpose Market Outlook Trends
7.1. Global Food for Special Medical Purpose Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Food for Special Medical Purpose Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Food for Special Medical Purpose Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 8. Global Food for Special Medical Purpose Regional Analysis and Outlook
8.1. Global Food for Special Medical Purpose Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Food for Special Medical Purpose Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Food for Special Medical Purpose Regional Analysis and Outlook
8.2.2. Canada Food for Special Medical Purpose Regional Analysis and Outlook
8.2.3. Mexico Food for Special Medical Purpose Regional Analysis and Outlook
8.3. Europe Food for Special Medical Purpose Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Food for Special Medical Purpose Regional Analysis and Outlook
8.3.2. France Food for Special Medical Purpose Regional Analysis and Outlook
8.3.3. United Kingdom Food for Special Medical Purpose Regional Analysis and Outlook
8.3.4. Spain Food for Special Medical Purpose Regional Analysis and Outlook
8.3.5. Italy Food for Special Medical Purpose Regional Analysis and Outlook
8.3.6. Russia Food for Special Medical Purpose Regional Analysis and Outlook
8.3.7. Rest of Europe Food for Special Medical Purpose Regional Analysis and Outlook
8.4. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) by Country (2021-2032)
8.4.1. China Food for Special Medical Purpose Regional Analysis and Outlook
8.4.2. Japan Food for Special Medical Purpose Regional Analysis and Outlook
8.4.3. India Food for Special Medical Purpose Regional Analysis and Outlook
8.4.4. South Korea Food for Special Medical Purpose Regional Analysis and Outlook
8.4.5. Australia Food for Special Medical Purpose Regional Analysis and Outlook
8.4.6. South East Asia Food for Special Medical Purpose Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Food for Special Medical Purpose Regional Analysis and Outlook
8.5. South America Food for Special Medical Purpose Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Food for Special Medical Purpose Regional Analysis and Outlook
8.5.2. Argentina Food for Special Medical Purpose Regional Analysis and Outlook
8.5.3. Rest of South America Food for Special Medical Purpose Regional Analysis and Outlook
8.6. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Food for Special Medical Purpose Regional Analysis and Outlook
8.6.2. Africa Food for Special Medical Purpose Regional Analysis and Outlook
Chapter 9. North America Food for Special Medical Purpose Analysis and Outlook
9.1. North America Food for Special Medical Purpose Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Food for Special Medical Purpose Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Food for Special Medical Purpose Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Food for Special Medical Purpose Revenue (USD Million) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 10. Europe Food for Special Medical Purpose Analysis and Outlook
10.1. Europe Food for Special Medical Purpose Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Food for Special Medical Purpose Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Food for Special Medical Purpose Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Food for Special Medical Purpose Revenue (USD Million) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 11. Asia Pacific Food for Special Medical Purpose Analysis and Outlook
11.1. Asia Pacific Food for Special Medical Purpose Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 12. South America Food for Special Medical Purpose Analysis and Outlook
12.1. South America Food for Special Medical Purpose Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Food for Special Medical Purpose Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Food for Special Medical Purpose Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Food for Special Medical Purpose Revenue (USD Million) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 13. Middle East and Africa Food for Special Medical Purpose Analysis and Outlook
13.1. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) by Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Chapter 14. Food for Special Medical Purpose Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Danone S.A.
Darman Ara Corp
GFI - Gruppo Farmaimpresa
Guangzhou New Health Biotechnology Co. Ltd
LENUS Pharma GesmbH
Mead Johnson & Company LLC
Nestlé S.A.
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Food for Special Medical Purpose Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Food for Special Medical Purpose Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Food for Special Medical Purpose Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Food for Special Medical Purpose Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Food for Special Medical Purpose Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Food for Special Medical Purpose Market Share (%) By Regions (2021-2032)
Table 12 North America Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Table 15 South America Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Table 17 North America Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Table 18 North America Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Table 19 North America Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Table 26 South America Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Table 27 South America Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Table 28 South America Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Food for Special Medical Purpose Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Food for Special Medical Purpose Market Share (%) By Regions (2023)
Figure 6. North America Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 12. France Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 12. China Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 14. India Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Food for Special Medical Purpose Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Food for Special Medical Purpose Revenue (USD Million) By Product (2021-2032)
By Type
Nutritionally Complete Foods
Nutritionally Complete Foods with A Disease
Nutritionally Incomplete Foods
By Form
Oral
Injectable
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Food for Special Medical Purpose Market Size is valued at $XX Million in 2024 and is forecast to register a growth rate (CAGR) of 7.1% to reach $XX Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Danone S.A., Darman Ara Corp, GFI - Gruppo Farmaimpresa, Guangzhou New Health Biotechnology Co. Ltd, LENUS Pharma GesmbH, Mead Johnson & Company LLC , Nestlé S.A.
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume